Opportunity Map catalyst · 2026-10-07 · version 1

    Neogen posts Q1 earnings beat with revenue up 6.5% YoY to $222.8M and EPS of $0.08

    Question

    Neogen posts Q1 earnings beat with revenue up 6.5% YoY to $222.8M and EPS of $0.08

    Direct answer

    Neogen reported fiscal Q1 2026 results that exceeded consensus estimates across top and bottom lines. Total revenue climbed 6.5% year-over-year to $222.8 million, topping the Street projection of $208.09 million by 7.07%. Diluted earnings per share came in at $0.08, exceeding the forecasted $0.05 by 60%, with primary strength coming from the core Food Safety division. — bullish pressure on NEOG.

    Original publisher
    Market Ontology
    Evidence through
    2026-10-07
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Neogen posts Q1 earnings beat with revenue up 6.5% YoY to $222.8M and EPS of $0.08”, revision 1, evidence through 2026-10-07. https://marketontology.com/catalysts/2026-10-07/neogen-posts-q1-earnings-beat-with-revenue-up-6-5-yoy-to-222-8m-and-eps-of-0-08-0a9ee4

    AssetDirectionTimeframeChannelScore
    NEOG▲Bull1–5 daysCatalyst Driven
    60
    Catalyst Driven·Healthcare·Equity·expired

    Neogen posts Q1 earnings beat with revenue up 6.5% YoY to $222.8M and EPS of $0.08

    Thesis

    Neogen reported fiscal Q1 2026 results that exceeded consensus estimates across top and bottom lines. Total revenue climbed 6.5% year-over-year to $222.8 million, topping the Street projection of $208.09 million by 7.07%. Diluted earnings per share came in at $0.08, exceeding the forecasted $0.05 by 60%, with primary strength coming from the core Food Safety division. — bullish pressure on NEOG.

    Neogen reported fiscal Q1 2026 results that exceeded consensus estimates across top and bottom lines. Total revenue climbed 6.5% year-over-year to $222.8 million, topping the Street projection of $208.09 million by 7.07%. Diluted earnings per share came in at $0.08, exceeding the forecasted $0.05 by 60%, with primary strength coming from the core Food Safety division.

    Transmission path
    01 · Catalyst
    Neogen posts Q1 earnings beat with revenue up 6.5% YoY to $222.8M and EPS of $0.08
    02 · Mechanism
    Positive operational earnings surprise of 60% drives forward margin repricing and short-term multiple expansion for NEOG.
    03 · Asset response
    bullish NEOG
    Source evidence
    • SummaryNeogen reported fiscal Q1 2026 results that exceeded consensus estimates across top and bottom lines. Total revenue climbed 6.5% year-over-year to $222.8 million, topping the Street projection of $208.09 million by 7.07%. Diluted earnings per share came in at $0.08, exceeding the forecasted $0.05 by 60%, with primary strength coming from the core Food Safety division.
    Possible expressions
    • NEOGDirect directional exposure

    Illustrative, not advice

    Risks
    • Crowded positioning may already reflect the move
    • Counter-catalyst could neutralize the thesis before window closes
    Invalidation
    • NEOG closes below pre-catalyst level on rising volume
    • Catalyst narrative is officially walked back or contradicted
    • Cross-asset confirmation (rates / FX / vol) reverses direction
    Monitor
    • NEOG price vs. pre-event level
    • NEOG volume vs. 20-day average

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    NEOGBullishagreed11.68 2026-10-07+0.26%PendingPending

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related catalysts

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month